Cargando…

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial

BACKGROUND: Smoking rates are high in adults with anxiety disorders (ADs), yet little is known about the safety and efficacy of smoking‐cessation pharmacotherapies in this group. METHODS: Post hoc analyses in 712 smokers with AD (posttraumatic stress disorder [PTSD], n = 192; generalized anxiety dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayers, Catherine R., Heffner, Jaimee L., Russ, Cristina, Lawrence, David, McRae, Thomas, Evins, A. Eden, Anthenelli, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064930/ https://www.ncbi.nlm.nih.gov/pubmed/31850603 http://dx.doi.org/10.1002/da.22982

Ejemplares similares

Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES
por: West, Robert, et al.
Publicado: (2018)

Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors
por: Beard, Emma, et al.
Publicado: (2021)

Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial()
por: McKee, Sherry A., et al.
Publicado: (2023)

Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial
por: Nollen, Nicole L., et al.
Publicado: (2021)

Pharmacotherapy of smoking cessation
por: Jiloha, R. C.
Publicado: (2014)

Optimal use of smoking cessation pharmacotherapy
por: Mendelsohn, Colin
Publicado: (2022)

A Pilot Randomized Controlled Trial of a Web-Based Growth Mindset Intervention to Enhance the Effectiveness of a Smartphone App for Smoking Cessation
por: Sridharan, Vasundhara, et al.
Publicado: (2019)

Review of pharmacotherapy for smoking cessation in patients with schizophrenia
por: Shawen, Avery E., et al.
Publicado: (2018)

Systematic review and meta-analysis of opioid antagonists for smoking cessation
por: David, Sean P, et al.
Publicado: (2014)

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
por: Baker, Christine L, et al.
Publicado: (2018)

Effectiveness of pharmacotherapy for smoking cessation: protocol for umbrella review and quality assessment of systematic reviews
por: Melka, Alemu S., et al.
Publicado: (2018)

Characterizing Participant Perceptions about Smoking-Cessation Pharmacotherapy and E-Cigarettes from Facebook Smoking-Cessation Support Groups
por: Lee, Allison, et al.
Publicado: (2022)

Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation
por: Ferguson, Stuart G., et al.
Publicado: (2015)

Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
por: Truong, Van Thi Thanh, et al.
Publicado: (2023)

U Can't Touch This With Pharmacotherapy Alone for Weight Loss or Smoking Cessation
por: Curtiss, Frederic R.
Publicado: (2005)

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
por: Gonzales, D, et al.
Publicado: (2014)

Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
por: Walker, N. J., et al.
Publicado: (2016)

Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
por: Corelli, Robin L., et al.
Publicado: (2021)

Trajectories of 12-Month Usage Patterns for Two Smoking Cessation Websites: Exploring How Users Engage Over Time
por: Bricker, Jonathan B, et al.
Publicado: (2018)

Does Effectiveness of Adolescent Smoking-Cessation Intervention Endure Into Young Adulthood? 7-Year Follow-Up Results from a Group-Randomized Trial
por: Peterson, Arthur V., et al.
Publicado: (2016)

Comparing Treatment Acceptability and 12-Month Cessation Rates in Response to Web-Based Smoking Interventions Among Smokers Who Do and Do Not Screen Positive for Affective Disorders: Secondary Analysis
por: Watson, Noreen L, et al.
Publicado: (2019)

Integrated Smoking Cessation for Smokers With Serious Mental Illness: Protocol for a Convergent Mixed Methods Implementation Evaluation Study
por: Schnitzer, Kristina, et al.
Publicado: (2021)

Erratum to: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service
por: Walker, N. J., et al.
Publicado: (2017)

Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia
por: Havard, Alys, et al.
Publicado: (2021)

An Avatar-Led Web-Based and SMS Text Message Smoking Cessation Program for Socioeconomically Disadvantaged Veterans: Pilot Randomized Controlled Trial
por: Heffner, Jaimee L, et al.
Publicado: (2023)

Smoking cessation or initiation: The paradox of vaping
por: Al-Hamdani, Mohammed, et al.
Publicado: (2021)

An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts
por: Bader, P, et al.
Publicado: (2009)

Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey
por: Siahpush, Mohammad, et al.
Publicado: (2015)

Inequalities in the Impact of National Reimbursement of Smoking Cessation Pharmacotherapy and the Influence of Injunctive Norms: An Explorative Study
por: Benson, Fiona E., et al.
Publicado: (2016)

Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders
por: Talukder, Saki Rubaiya, et al.
Publicado: (2023)

An Avatar-Led Digital Smoking Cessation Program for Sexual and Gender Minority Young Adults: Intervention Development and Results of a Single-Arm Pilot Trial
por: Heffner, Jaimee L, et al.
Publicado: (2021)

Pharmacotherapy in Tobacco Cessation: A Narrative Review
por: Pajai, Devanjali D, et al.
Publicado: (2023)

A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
por: Rennard, Stephen, et al.
Publicado: (2012)

A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention
por: Gonseth, Semira, et al.
Publicado: (2010)

Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial
por: Nollen, Nicole L., et al.
Publicado: (2023)

2831. Efficacy and Safety of Gepotidacin for Uncomplicated Urinary Tract Infection: Pooled Subgroup Analyses of the EAGLE-2 and EAGLE-3 Randomized Phase 3 Trials
por: Hooton, Thomas M, et al.
Publicado: (2023)

Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial
por: Tønnesen, Philip, et al.
Publicado: (2022)

Truck Drivers’ Cigarette Smoking and Preferred Smoking Cessation Methods
por: Kagabo, Robert, et al.
Publicado: (2020)

Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation
por: Roper, Lucinda, et al.
Publicado: (2018)

An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders
por: Breitborde, Nicholas J. K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42b754jllfr7g3th5had3rhovd